A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly

References

• VincentGKVelkoffVAThe Next Four Decades. The Older Population in the United States: 2010 to 2050WashingtonUS Census Bureau2010 Available from: http://www.census.gov/prod/2010pubs/p25-1138.pdf. Accessed December 18, 2010
   Google Scholar
• JohansonJFMortonDGeenenJUenoRMulticenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipationAm J Gastroenterol2008103117017717916109
   PubMed Web of Science ®Google Scholar
• WaldAScarpignatoCMueller-LissnerSA multinational survey of prevalence and patterns of laxative use among adults with self-defined constipationAliment Pharmacol Ther200828791793018644012
   PubMed Web of Science ®Google Scholar
• TalleyNJFlemingKCEvansJMConstipation in an elderly community: a study of prevalence and potential risk factorsAm J Gastroenterol199691119258561137
   PubMed Web of Science ®Google Scholar
• WolfsenCRBarkerJCMittenessLSConstipation in the daily lives of frail elderly peopleArch Fam Med1993288538588111515
   PubMedGoogle Scholar
• FukudoSHongoMKanekoHUenoREfficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding studyNeurogastroenterol Motil2011236544e20521303430
   PubMed Web of Science ®Google Scholar
• BosshardWDreherRSchneggJFBülaCJThe treatment of chronic constipation in elderly people: an updateDrugs Aging2004211491193015554750
   PubMed Web of Science ®Google Scholar
• MihaylovSStarkCMcCollEStepped treatment of older adults on laxatives. The STOOL trialHealth Technol Assess20081213iiiivix13918462572
   PubMed Web of Science ®Google Scholar
• O’KeefeEATalleyNJZinsmeisterARJacobsenSJBowel disorders impair functional status and quality of life in the elderly: a population-based studyJ Gerontol A Biol Sci Med Sci1995504M184M1897614239
   PubMed Web of Science ®Google Scholar
• RaoSSGoJTUpdate on the management of constipation in the elderly: new treatment optionsClin Interv Aging2010516317120711435
   PubMed Web of Science ®Google Scholar
• GliaALindbergGQuality of life in patients with different types of functional constipationScand J Gastroenterol19973211108310899399387
   PubMed Web of Science ®Google Scholar
• CharachGGreensteinARabinovichPGroskopfIWeintraubMAlleviating constipation in the elderly improves lower urinary tract symptomsGerontology2001472727611287730
   PubMed Web of Science ®Google Scholar
• LemboACamilleriMChronic constipationN Engl J Med2003349141360136814523145
   PubMed Web of Science ®Google Scholar
• McCormickAFlemingDCharltonJMorbidity Statistics from General Practice: Fourth National Study: 1991–1992LondonHMSO1995
   Google Scholar
• McCreaGLMiaskowskiCStottsNAMaceraLVarmaMGA review of the literature on gender and age differences in the prevalence and characteristics of constipation in North AmericaJ Pain Symptom Manage200937473774518789639
   PubMed Web of Science ®Google Scholar
• HeymenSScarlettYJonesKRingelYDrossmanDWhiteheadWERandomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipationDis Colon Rectum200750442844117294322
   PubMed Web of Science ®Google Scholar
• RaoSSSeatonKMillerMRandomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecationClin Gastroenterol Hepatol20075333133817368232
   PubMed Web of Science ®Google Scholar
• CamilleriMLeeJSViramontesBBharuchaAETangalosEGInsights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older peopleJ Am Geriatr Soc20004891142115010983917
   PubMed Web of Science ®Google Scholar
• SimónMABuenoAMBehavioural treatment of the dyssynergic defecation in chronically constipated elderly patients: a randomized controlled trialAppl Psychophysiol Biofeedback200934427327719618262
   PubMed Web of Science ®Google Scholar
• HanlonJTFillenbaumGGRubyCMGraySBohannonAEpidemiology of over-the-counter drug use in community dwelling elderly: United States perspectiveDrugs Aging200118212313111346126
   PubMed Web of Science ®Google Scholar
• StoehrGPGanguliMSeabergECEchementDABelleSOver-the-counter medication use in an older rural community: the MoVIES ProjectJ Am Geriatr Soc19974521581659033513
   PubMed Web of Science ®Google Scholar
• GohLYVitryAISempleSJEstermanALuszczMASelf-medication with over-the-counter drugs and complementary medications in South Australia’s elderly populationBMC Complement Altern Med200994219906314
   PubMed Web of Science ®Google Scholar
• AnrakuMInoueHSatoESurveillance study in collaboration with a university-daycare center for elderly people and nursery school for children on the use of over-the-counter drugs and health food in FukuyamaYakugaku Zasshi2010130810931103 Japanese20686214
   PubMed Web of Science ®Google Scholar
• AlbertNMRathmanLRossDPredictors of over-the-counter drug and herbal therapies use in elderly patients with heart failureJ Card Fail200915760060619700137
   PubMed Web of Science ®Google Scholar
• DiPalmaJAClevelandMBMcGowanJHerreraJLA comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medicationsSouth Med J2007100111085109017984738
   PubMed Web of Science ®Google Scholar
• DiPalmaJAClevelandMVMcGowanJHerreraJLA randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipationAm J Gastroenterol200710271436144117403074
   PubMed Web of Science ®Google Scholar
• LemboAJKurtzCBMacdougallJEEfficacy of linaclotide for patients with chronic constipationGastroenterology2010138388689520045700
   PubMed Web of Science ®Google Scholar
• Mueller-LissnerSRykxAKerstensRVandeplasscheLRandomized double-blind placebo-controlled trial to evaluate efficacy and safety of prucalopride (Resolor®) in elderly patients with chronic constipationGastroenterology20081344 Suppl 1A-157 Abstract 1052
   Google Scholar
• CamilleriMBeyensGKerstensRRobinsonPVandeplasscheLSafety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled studyNeurogastroenterol Motil200921121256e111719751247
   PubMed Web of Science ®Google Scholar
• FlemingVWadeWEA review of laxative therapies for treatment of chronic constipation in older adultsAm J Geriatr Pharmacother20108651455021356503
   PubMedGoogle Scholar
• ChamberlainSMRaoSSSafety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndromeExpert Opin Drug Saf201211584185022834474
   PubMed Web of Science ®Google Scholar
• CamilleriMBharuchaAEUenoREffect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteersAm J Physiol Gastrointest Liver Physiol20062905G942G94716603730
   PubMed Web of Science ®Google Scholar
• JohansonJFUenoRLubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safetyAliment Pharmacol Ther200725111351136117509103
   PubMed Web of Science ®Google Scholar
• BarishCFDrossmanDJohansonJFUenoREfficacy and safety of lubiprostone in patients with chronic constipationDig Dis Sci20105541090109720012484
   PubMed Web of Science ®Google Scholar
• SuaresNCFordACEfficacy of lubiprostone in the treatment of chronic idiopathic constipation: systematic review and meta-analysisGut201160Suppl 1A164A165 Abstract
   Web of Science ®Google Scholar
• LemboAJJohansonJFParkmanHPRaoSSMinerPBJrUenoRLong-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipationDig Dis Sci20115692639264521769655
   PubMed Web of Science ®Google Scholar
• DrossmanDACheyWDJohansonJFClinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studiesAliment Pharmacol Ther200929332934119006537
   PubMed Web of Science ®Google Scholar
• CheyWDDrossmanDAJohansonJFScottCPanasRMUenoRSafety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipationAliment Pharmacol Ther201235558759922251419
   PubMed Web of Science ®Google Scholar
• UenoRJoswickTRWahleAZhuYHollandPCEfficacy and safety of lubiprostone for the treatment of chronic constipation in elderly vs non-elderly subjectsGastroenterology2006130Suppl 2A189 Abstract S1262
   Google Scholar
• UenoRPanasRWahleAZhuYHollandPCLong-term safety and efficacy of lubiprostone for the treatment of chronic constipation in elderly subjectsGastroenterology2006130Suppl 2A-188 Abstract S1260
   Google Scholar
• UenoRWahleARiveraEPooled analysis of the most frequent adverse events associated with the use of lubiprostoneAm J Gastroenterol2006101Suppl 2S489 Abstract 1264
   Web of Science ®Google Scholar
• SprengerCCopaAMorganrothJEffect of lubiprostone, a unique agent for the treatment of chronic idiopathic constipation, on clinical electrocardiogram resultsGastroenterology2007132A325 Abstract
   Web of Science ®Google Scholar
• MostileGJankovicJTreatment of dysautonomia associated with Parkinson’s diseaseParkinsonism Relat Disord200915Suppl 3S224S23220082997
   PubMed Web of Science ®Google Scholar
• OndoWGKenneyCSullivanKPlacebo-controlled trial of lubiprostone for constipation associated with Parkinson diseaseNeurology201278211650165422573627
   PubMed Web of Science ®Google Scholar
• KroghKChristensenPNeurogenic colorectal and pelvic floor dysfunctionBest Pract Res Clin Gastroenterol200923453154319647688
   PubMed Web of Science ®Google Scholar
• HonigHAntoniniAMartinez-MartinPIntrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of lifeMov Disord200924101468147419425079
   PubMed Web of Science ®Google Scholar
• AstarloaRMenaMASánchezVde la VegaLde YébenesJGClinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson diseaseClin Neuropharmacol19921553753801330307
   PubMed Web of Science ®Google Scholar
• AshrafWPfeifferRFParkFLofJQuigleyEMConstipation in Parkinson’s disease: objective assessment and response to psylliumMov Disord19971269469519399219
   PubMed Web of Science ®Google Scholar
• SakakibaraRYamaguchiTUchiyamaTCalcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjectsMov Disord200722111672167317149723
   PubMed Web of Science ®Google Scholar
• BassottiGMaggioDBattagliaEManometric investigation of anorectal function in early and late stage Parkinson’s diseaseJ Neurol Neurosurg Psychiatry200068676877010811703
   PubMed Web of Science ®Google Scholar
• ZangagliaRMartignoniEGloriosoMMacrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled studyMov Disord20072291239124417566120
   PubMed Web of Science ®Google Scholar
• SadjadpourKPyridostigmine bromide and constipation in Parkinson’s diseaseJAMA1983249911486823069
   PubMed Web of Science ®Google Scholar
• JostWHSchimrigkKLong-term results with cisapride in Parkinson’s diseaseMov Disord19971234234259159740
   PubMed Web of Science ®Google Scholar
• CadedduFBentivoglioARBrandaraFMarnigaGBrisindaGMariaGOutlet type constipation in Parkinson’s disease: results of botulinum toxin treatmentAliment Pharmacol Ther20052210997100316268975
   PubMed Web of Science ®Google Scholar
• TrescotAMGlaserSEHansenHBenyaminRPatelSManchikantiLEffectiveness of opioids in the treatment of chronic non-cancer painPain Physician200811Suppl 2S181S20018443639
   PubMed Web of Science ®Google Scholar
• GianniWCeciMBustacchiniSOpioids for the treatment of chronic non-cancer pain in older peopleDrugs Aging200926Suppl 1S63S73
   PubMed Web of Science ®Google Scholar
• van OjikALJansenPABrouwersJRvan RoonENTreatment of chronic pain in older people: evidence-based choice of strong-acting opioidsDrugs Aging201229861562522765848
   PubMed Web of Science ®Google Scholar
• De SchepperHUCremoniniFParkMICamilleriMOpioids and the gut: pharmacology and current clinical experienceNeurogastroenterol Motil200416438339415305992
   PubMed Web of Science ®Google Scholar
• KalsoEEdwardsJEMooreRAMcQuayHJOpioids in chronic non-cancer pain: systematic review of efficacy and safetyPain2004112337238015561393
   PubMed Web of Science ®Google Scholar
• PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg2001182Suppl 5AS11S18
   Web of Science ®Google Scholar
• WebsterLJansenJPPeppinJAlvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer painPain2008137242844018164818
   PubMed Web of Science ®Google Scholar
• MichnaEBlonskyERSchulmanSSubcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled studyJ Pain201112555456221429809
   PubMed Web of Science ®Google Scholar
• ItawiEASavoieLMHannaAJApostolidesGYAlvimopan addition to a standard perioperative recovery pathwayJSLS201115449249822643504
   PubMed Web of Science ®Google Scholar
• SawhSBSelvarajIPDangaACottonALMossJPatelPBUse of methylnaltrexone for the treatment of opioid-induced constipation in critical care patientsMayo Clin Proc201287325525922386181
   PubMed Web of Science ®Google Scholar
• GattiASabatoAFManagement of opioid-induced constipation in cancer patients: focus on methylnaltrexoneClin Drug Investig2012325293301
   PubMed Web of Science ®Google Scholar
• FeiGRaehalKLiuSLubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouseJ Pharmacol Exp Ther2010334133334020406855
   PubMed Web of Science ®Google Scholar
• SunXWangXWangGDLubiprostone reverses the inhibitory action of morphine on mucosal secretion in human small intestineDig Dis Sci201156233033821181441
   PubMed Web of Science ®Google Scholar
• CryerBLKatzSVallejoRA phase 3, randomised, double-blind, placebo controlled clinical trial of lubiprostone for the treatment of opioid-induced bowel dysfunction in patients with chronic non-cancer painGastroenterology2010138Suppl 1S-129 Abstract 906
   Google Scholar
• JamalMMareyaSWoldegeorgisFJoswickTUenoRLubiprostone significantly improves treatment response in non-methadone opioid-induced bowel dysfunction patients with chronic, non-cancer pain: Results from a phase 3, randomized, double-blind, placebo-controlled clinical trialGastroenterology20121425 Suppl 1S144S145 Abstract 848a
   Web of Science ®Google Scholar
• Sucampo Pharmaceuticals. Takeda and Sucampo report top-line results of two phase 3 trials of lubiprostone in opioid-induced bowel dysfunction [press release]. Bethesda, MD: Sucampo Pharmaceuticals Inc; 2009 [Jul 21]. Available from: http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=1309679&highlight=. 2009. Accessed December 18, 2012
   Google Scholar
• Sucampo Pharmaceuticals. Positive top-line results from phase 3 long-term, open-label safety and efficacy trial of lubiprostone in opioid-induced bowel dysfunction patients [press release]. Bethesda, MD: Sucampo Pharmaceuticals; 2012 [Apr 5]. Available from: http://investor.sucampo.com/phoenix.zhtml?c=201197&p=irol-newsArticle&ID=1680449&highlight=. 2012. Accessed December 18, 2012
   Google Scholar